PlainRecalls
FDA Drug Moderate Class II Terminated

Fexofenadine HCl Tablets, USP, 180 mg, packaged in a) 30-count bottles (NDC 0378-0782-93) and b) 500-count bottles (NDC 0378-0782-05); Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.

Reported: February 6, 2019 Initiated: January 18, 2019 #D-0428-2019

Product Description

Fexofenadine HCl Tablets, USP, 180 mg, packaged in a) 30-count bottles (NDC 0378-0782-93) and b) 500-count bottles (NDC 0378-0782-05); Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.

Reason for Recall

Failed Impurities/Degradation Specifications: Related compound results obtained during routine stability testing was slightly elevated above specification.

Details

Units Affected
88,090 bottles
Distribution
Nationwide in the USA
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Fexofenadine HCl Tablets, USP, 180 mg, packaged in a) 30-count bottles (NDC 0378-0782-93) and b) 500-count bottles (NDC 0378-0782-05); Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 88,090 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Related compound results obtained during routine stability testing was slightly elevated above specification.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 6, 2019. Severity: Moderate. Recall number: D-0428-2019.